<DOC>
	<DOCNO>NCT01937286</DOCNO>
	<brief_summary>Within community high incidence HCC , stretch limit could justify base tumor character biological behavior</brief_summary>
	<brief_title>Single Center Experience Over Decade Living Donor Liver Transplantation Egyptian Patients With Hepatocellular Carcinoma : Stretching Limits</brief_title>
	<detailed_description>590 Egyptian patient underwent LDLT ; , 172 ( 32 % ) patient transplant HCC . Twenty six case ( 15.1 % ) exclude due early postoperative mortality ( n=22 ) due non HCC related mortality ( n=4 ) . One hundred forty six patient retrospectively review determine prognostic factor recurrence .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Egyptien Patients HCC Patients within Milan Criteria Patients beyond Milan criterion select case case basis 2005 . From 2005 , patient beyond Milan criterion subject stag protocol reassess ( pre transplantation local ablative therapy either RFA TACE accord size site lesion wait 12 week ablation , well ablated lesion , decrease AFP denovo lesion transplant ) . • Evidence macro vascular invasion CT portography and/or US duplex . Metastatic HCC General contraindication LT ( ongoing sepsis , major co morbidity , … ) . Early postoperative mortality ( first1 month ) . Post transplant mortality period follow due cause recurrent HCC ( e.g . sepsis , rejection , cardiological cerebrovascular complications… )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>62 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>LDLT , HCC , Microvascular invasion</keyword>
</DOC>